Immix Biopharma Stock (NASDAQ:IMMX), Quotes and News Summary

Q: What sector and industry does Immix Biopharma (IMMX) operate in?

Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immix Biopharma Stock (NASDAQ: IMMX) stock price, news, charts, stock research, profile.

Open	$2.350
Close	-
Volume / Avg.	24.846K / 176.825K
Day Range	2.250 - 2.430
52 Wk Range	1.400 - 7.750
Market Cap	$61.809M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	5.13%
Days to Cover	2.37

Recent News

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.

Avi Kapoor

What's Going On With Cancer-Focused Immix Biopharma Stock Today?

Immix Biopharma Inc (NASDAQ: IMMX) announced the presentation of updated data from the ongoing Phase 1b/2 NEXICART-1 study of its NXC-201, an autologous, BCMA-targeted chimeric antigen receptor T

Vandana Singh

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immix Biopharma (IMMX) stock?

You can purchase shares of Immix Biopharma (NASDAQ: IMMX) through any online brokerage.

View our list of the best stock brokerages.

Who are Immix Biopharma's (IMMX) competitors?

Other companies in Immix Biopharma’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).

What is the target price for Immix Biopharma (IMMX) stock?

The latest price target for Immix Biopharma (NASDAQ: IMMX) was reported by Roth MKM on Monday, August 14, 2023. The analyst firm set a price target for 14.00 expecting IMMX to rise to within 12 months (a possible 498.29% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Immix Biopharma (IMMX)?

The stock price for Immix Biopharma (NASDAQ: IMMX) is $2.34 last updated Today at May 17, 2024 at 9:27 AM EDT.

Does Immix Biopharma (IMMX) pay a dividend?

There are no upcoming dividends for Immix Biopharma.

When is Immix Biopharma (NASDAQ:IMMX) reporting earnings?

Immix Biopharma’s Q2 earnings are confirmed for Friday, August 9, 2024.

Is Immix Biopharma (IMMX) going to split?

There is no upcoming split for Immix Biopharma.

What sector and industry does Immix Biopharma (IMMX) operate in?

Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-